Clinical trial
Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)
NCT00099463 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00099463 |
|---|---|
| Title | Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS) |
| Official title | A Phase I Study of the Safety and Immunogenicity of a SARS Recombinant DNA Plasmid Vaccine, VRC-SRSDNA015-00-VP, in Healthy Adult Volunteers |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug, Procedure |
| Interventions | Blood Test, Urine Test, Physical Exam, Vaccine, VRC-SRSDNA015-00-VP |
| Enrollment | 10 |
| Start date | Dec 9, 2004 |
| Completion | Aug 22, 2007 |
| First posted | Dec 15, 2004 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: